| Product Code: ETC10797220 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Pharmacogenomics Technology Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Romania Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Romania Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Romania Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Romania Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Romania Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Romania Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing focus on personalized medicine and targeted therapies |
3.9.2 Growing awareness about the benefits of pharmacogenomics in improving patient outcomes |
3.9.3 Government initiatives to promote the adoption of pharmacogenomics technology |
4 Romania Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 High costs associated with pharmacogenomics testing and technology |
4.3.2 Limited reimbursement policies for pharmacogenomics services |
4.3.3 Lack of skilled professionals in the field of pharmacogenomics |
5 Romania Pharmacogenomics Technology Market Trends |
6 Romania Pharmacogenomics Technology Market, By Types |
6.1 Romania Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Romania Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Romania Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 Romania Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 Romania Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 Romania Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 Romania Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 Romania Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Romania Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 Romania Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 Romania Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 Romania Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 Romania Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 Romania Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Romania Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 Romania Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 Romania Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 Romania Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 Romania Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 Romania Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Romania Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Romania Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Romania Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Romania Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 Romania Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Romania Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 Romania Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 Romania Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 Romania Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 Romania Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 Romania Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 Romania Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 Romania Pharmacogenomics Technology Market Export to Major Countries |
7.2 Romania Pharmacogenomics Technology Market Imports from Major Countries |
8 Romania Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenomics technology in healthcare institutions |
8.2 Number of research studies and publications related to pharmacogenomics in Romania |
8.3 Rate of integration of pharmacogenomics data into electronic health records |
9 Romania Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 Romania Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Romania Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Romania Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Romania Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Romania Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 Romania Pharmacogenomics Technology Market - Competitive Landscape |
10.1 Romania Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 Romania Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here